Methylprednisolone in adults hospitalized with COVID-19 pneumoniaAn open-label randomized trial (GLUCOCOVID)

被引：0
|
作者：
Luis Corral-Gudino
Alberto Bahamonde
Francisco Arnaiz-Revillas
Julia Gómez-Barquero
Jesica Abadía-Otero
Carmen García-Ibarbia
Víctor Mora
Ana Cerezo-Hernández
José L. Hernández
Graciela López-Muñíz
Fernando Hernández-Blanco
Jose M. Cifrián
Jose M. Olmos
Miguel Carrascosa
Luis Nieto
María Carmen Fariñas
José A. Riancho
机构：
[1] Universidad de Valladolid,Hospital Rio Hortega, Servicio de Medicina Interna
[2] Hospital Bierzo,Servicio de Medicina Interna
[3] Universidad de Cantabria,IDIVAL, Hospital U M Valdecilla, Servicio de Enfermedades Infecciosas
[4] Universidad de Valladolid,Hospital Rio Hortega, Servicio de Medicina Interna, Consulta de Enfermedades Infecciosas
[5] Universidad de Cantabria,IDIVAL, Hospital U M Valdecilla, Servicio de Medicina Interna
[6] Universidad de Cantabria,IDIVAL, Hospital U M Valdecilla, Servicio de Neumología
[7] Hospital Universitario Río Hortega,Servicio de Neumología
[8] Hospital Laredo,Servicio de Medicina Interna
[9] Hospital Sierrallana,Servicio de Medicina Interna
来源：
Wiener klinische Wochenschrift | 2021年 / 133卷
关键词：
Glucocorticoids; SARS-CoV-2; Mortality; Coronavirus Infections; Humans;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：303 / 311
页数：8
相关论文
共 50 条
  • [1] Methylprednisolone in adults hospitalized with COVID-19 pneumonia An open-label randomized trial (GLUCOCOVID)
    Corral-Gudino, Luis
    Bahamonde, Alberto
    Arnaiz-Revillas, Francisco
    Gomez-Barquero, Julia
    Abadia-Otero, Jesica
    Garcia-Ibarbia, Carmen
    Mora, Victor
    Cerezo-Hernandez, Ana
    Hernandez, Jose L.
    Lopez-Muniz, Graciela
    Hernandez-Blanco, Fernando
    Cifrian, Jose M.
    Olmos, Jose M.
    Carrascosa, Miguel
    Nieto, Luis
    Farinas, Maria Carmen
    Riancho, Jose A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (7-8) : 303 - 311
  • [2] METHYLENE BLUE FOR TREATMENT OF HOSPITALIZED COVID-19 PATIENTS: A RANDOMIZED, CONTROLLED, OPEN-LABEL CLINICAL TRIAL, PHASE 2
    Hamidi-Alamdari, Daryoush
    Hafizi-Lotfabadi, Saied
    Bagheri-Moghaddam, Ahmad
    Safari, Hossin
    Mozdourian, Mahnaz
    Javidarabshahi, Zahra
    Peivandi-Yazdi, Arash
    Ali-Zeraati, Abass
    Sedaghat, Alireza
    Poursadegh, Farid
    Barazandeh-Ahmadabadi, Fatemeh
    Agheli-Rad, Marzieh
    Tavousi, Seyed M.
    Vojouhi, Shohreh
    Amini, Shahram
    Amini, Mahnaz
    Majid-Hosseini, Seyed
    Tavanaee-Sani, Ashraf
    Ghiabi, Amin
    Nabavi-Mahalli, Shima
    Morovatdar, Negar
    Rajabi, Omid
    Koliakos, George
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2021, 73 (03): : 190 - 198
  • [3] Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial
    Karampitsakos, Theodoros
    Papaioannou, Ourania
    Tsiri, Panagiota
    Katsaras, Matthaios
    Katsimpris, Andreas
    Kalogeropoulos, Andreas P.
    Malakounidou, Elli
    Zarkadi, Eirini
    Tsirikos, Georgios
    Georgiopoulou, Vasiliki
    Sotiropoulou, Vasilina
    Koulousousa, Electra
    Chourpiliadi, Charikleia
    Matsioulas, Apostolos
    Lagadinou, Maria
    Sampsonas, Fotios
    Akinosoglou, Karolina
    Marangos, Markos
    Tzouvelekis, Argyris
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (03) : 372 - 378
  • [4] Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients-An Open-Label Phase II Clinical Trial
    Rastvorceva, Rada M. Grubovic
    Useini, Sedula
    Stevanovic, Milena
    Demiri, Ilir
    Petkovic, Elena
    Franchini, Massimo
    Focosi, Daniele
    LIFE-BASEL, 2022, 12 (10):
  • [5] Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalised adults with severe COVID-19 pneumonia: An open-label randomised trial
    Corral-Gudino, Luis
    Cuascovich, Ivan
    Ignacio Martin-Gonzalez, Jose
    Muela-Molinero, Alberto
    Abadia-Otero, Jesica
    Gonzalez-Fuentes, Roberto
    Ruiz-de-Temino, Angela
    Tapia-Moral, Elena
    Cuadrado-Medina, Francisca
    Martin-Asenjo, Miguel
    Miramontes-Gonzalez, Pablo
    Luis Delgado-Gonzalez, Jose
    Ines, Sandra
    Abad-Manteca, Laura
    Usategui-Martin, Iciar
    Ruiz-Albi, Tomas
    Miranda-Riano, Sara
    Rodriguez-Forunez, Patricia
    Rodriguez-Jimenez, Consuelo
    Lopez-Franco, Esperanza
    Marcos, Miguel
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53 (01)
  • [6] Senicapoc treatment in COVID-19 patients with severe respiratory insufficiency-A randomized, open-label, phase II trial
    Granfeldt, Asger
    Andersen, Lars W.
    Vallentin, Mikael F.
    Hilberg, Ole
    Hasselstrom, Jorgen B.
    Sorensen, Lambert K.
    Mogensen, Susie
    Christensen, Steffen
    Grejs, Anders M.
    Rasmussen, Bodil S.
    Kristiansen, Klaus T.
    Strom, Thomas
    Johansen, Isik S.
    Schjorring, Olav L.
    Simonsen, Ulf
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2022, 66 (07) : 838 - 846
  • [7] Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study
    Lukito, Antonia Anna
    Widysanto, Allen
    Lemuel, Theo Audi Yanto
    Prasetya, Ignatius Bima
    Massie, Billy
    Yuniarti, Mira
    Lumbuun, Nicolaski
    Pranata, Raymond
    Meidy, Cindy
    Wahjoepramono, Eka Julianta
    Yusuf, Irawan
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 108 : 159 - 166
  • [8] A randomised, open-label trial of nebulised unfractionated heparin in patients mechanically ventilated for COVID-19
    Smith, Roger J.
    Ghosh, Angajendra N.
    Said, Simone
    van Haren, Frank M. P.
    Laffey, John G.
    Doig, Gordon S.
    Santamaria, John D.
    Dixon, Barry
    ANAESTHESIA AND INTENSIVE CARE, 2025,
  • [9] Timing of corticosteroids in non-severe non-hospitalized COVID-19 patients: open-label, two-center, randomized controlled study (TICS-COV19 study)
    Issak, Emad R.
    Amin, Mariam M.
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (02) : 207 - 217
  • [10] Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial
    Aghasadeghi, Mohammad Reza
    Zaheri Birgani, Mohammad Ali
    Jamalimoghadamsiyahkali, Saeedreza
    Hosamirudsari, Hadiseh
    Moradi, Ali
    Jafari-Sabet, Majid
    Sadigh, Nooshin
    Rahimi, Pooneh
    Tavakoli, Rezvan
    Hamidi-Fard, Mojtaba
    Bahramali, Golnaz
    Parmoon, Zohal
    Arjmand Hashjin, Sina
    Mirzajani, Ghasem
    Kouhkheil, Reza
    Roshangaran, Somayeh
    Khalaf, Samineh
    Khademi Nadoushan, Mohammad
    Gholamiyan Yousef Abad, Ghazaleh
    Shahryarpour, Nima
    Izadi, Mohammad
    Zendedel, Abolfazl
    Jahanfar, Shayesteh
    Dadras, Omid
    SeyedAlinaghi, SeyedAhmad
    Hackett, Daniel
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345